| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
-0.0063 |
0.9 |
| mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0063 |
0.9 |
| mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
0.0061 |
0.9 |
| mRNA |
Elesclomol |
GDSC1000 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |
| mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0058 |
0.9 |
| mRNA |
MG-132 |
GDSC1000 |
pan-cancer |
AAC |
0.0084 |
0.9 |
| mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
| mRNA |
BRD-K34485477 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.9 |